EFFICIENCY OF DIFFERENT DOSES OF RECOMBINANT HUMAN ERYTHROPOIETIN USED TO TREAT ANEMIA IN PREGNANCY
- Authors: Demikhov V.G1, Klimovskaya E.V2, Mirov I.M3, Zhurina O.N1, Golovitsyna O.A1, Morshchakova E.F1
-
Affiliations:
- Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
- City Clinical Hospital Eight, Ryazan
- Academician I.P. Pavlov Ryazan State Medical University
- Issue: No 1 (2011)
- Pages: 32-35
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246465
- ID: 246465
Cite item
Abstract
Keywords
Full Text
About the authors
V. G Demikhov
Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
Email: demix777@ya.ru
E. V Klimovskaya
City Clinical Hospital Eight, Ryazan
I. M Mirov
Academician I.P. Pavlov Ryazan State Medical University
O. N Zhurina
Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
O. A Golovitsyna
Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
E. F Morshchakova
Ryazan Branch, Federal Research and Clinical Center of Pediatric Hematology, Oncology, and Immunology
References
- Демихов В.Г. Этиология и патогенез анемии беременных // Вопр. гематол./онкол. и иммунопатол. в педиатрии. — 2004. — № 1. — С. 36—42.
- Демихов В.Г., Морщакова Е.Ф., Демихова Е.В. и др. Распространенность дефицита железа у беременных женщин // Вопр. гематол./онкол. и иммунопатол. в педиатрии. — 2002. — № 1. — С. 21—23.
- Железодефицитные состояния у беременных и родильниц: Учебное пособие. — М.: «Системные решения». — 2009.
- Румянцев А.Г., Морщакова Е.Ф., Павлов А.Д. Эритропоэтин: биологические свойства, возрастная регуляция эритропоэза, клиническое применение. — М.: ГЭОТАР-МЕД, 2003.
- Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. — М. — 1999. — С. 373—392.
- Alper B.S., Kimber R., Reddy A.K. Using ferritin levels to determine iron-deficiency anemia in pregnancy // J. Fam. Pract. — 2000. — Vol. 49, № 9. — P. 829—832.
- Auerbach M., Ballard H., Trout J.R., et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients withc hemotherapy-related anemia: a multicenter, open-label, randomized trial // J. Clin. Oncol. — 2004. — Vol. 22, № 7. — P. 1301—1307.
- Breymann C., Major A., Richter C. et al. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study // J. Perinat. Med. — 1995. —№ 23. — P. 89—98.
- Centers of Disease Control (CDC). Criteria for anemia in children and childbearing-aged women // Morbidity and Mortal. Wkly Rep. — 1989. — Vol. 38, № 22. — P. 400—404.
- Demikhov V.G., Morshchakova E.F., Pavlov A.D. Update of anemia in pregnancy pathogenesis // Hematologica. — 2005. — Vol. 90, Suppl. 2. — P. 330.
- Hedenus M., Birgegård G., Näsman P. et al. Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study // Leukemia. — 2007. — Vol. 21, № 4. — P. 627—632.
- Krafft A., Bencaiova G., Breymann C. Selective use of recombinant human erythropoietin in pregnant patients with sever anemia or nonresponsive to iron sucrose alone // Fetal Diagn. Ther. — 2009. — Vol. 25.— P. 239—245.
- Sifakis S., Pharmakides G. Anemia in pregnancy // Ann. N.Y. Acad. Sci. — 2000. — Vol. 900. — P. 125—136.
- Sifakis S., Angelakis E., Vardaki E. et al. Erythropoietin in the treatment of iron deficiency anemia during pregnancy. // Gynecol. Obstet. Invest. — 2001. — Vol. 51, № 3. — P. 150—156.